You are here
Increased toxicities from targeted cancer treatments
Interview with Paolo Bossi, MD, recorded at ESMO, September 2014.
Oncologists are employing more and more targeted therapies and are facing symptoms that they are not accustomed to observe. In this interview Dr. Paolo Bossi is giving answers to some important questions, e.g.: Which are the major difficulties a physician faces when assessing patients’ symptoms? What is the impact of new targeted therapies on patients’ quality of life? Are there any worrisome symptoms that could have a greater impact on the quality of life? Dr. Bossi’s take-home message: Listen to the patient, use new instruments for assessing symptoms, and inform the patient about acute and late toxicities.
Paolo Bossi, MD, is Medical Oncologist at the National Cancer Institute, Milan, Italy.